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Tax cost plays an important role in the operating cost of enterprises, and that 
effective tax planning can help taxpayers to save their tax cost and is helpful to the 
accomplishment of their strategic goal. However, the understanding about tax 
planning in China’s practical field is not mature yet: the goal of tax planning is just 
for the minimization of tax burden; when making tax planning decision, to take the 
current problem into account is enough. Tax planning scheme designed in this view 
would surely be deficient, that it is shortsighted, has a relatively higher tax planning 
risk and is harmful to the improve of Enterprise Value. In order to change this 
situation, this paper advocates such an viewpoint about tax planning: taxpayers 
should carry out tax planning under the direction of corporate strategy management, 
and take enterprise value maximization based on interests of those concerned as the 
goal of tax planning. 
At present, there is a great opportunity for China’s pharmaceutical industry, but 
it is also confronted with some challenges. On the one hand, benefited from the 
growth of national consumption demand, the arrival of ageing population society and 
the reform of medical insurance system, China’s pharmaceutical market has been in 
a process of rapid growth, which gives a great support to the development of China’s 
pharmaceutical industry; On the other hand, China’s pharmaceutical industry has 
several demerits: the scale of most enterprises is small, its research and development 
capabilities is poor and its profitability is deficient in the international market. These 
all place China’s pharmaceutical industry in a disadvantageous position. So, to 
emphasize new drug research and development, to focus on the Chinese medicine 
producing field and biological pharmaceutical field and to focus on special drug in 
chemical pharmaceutical field, are of significance to the long-term development of 
China’s pharmaceutical industry. 
Guided by the tax planning view advocated in this paper, here constructed a tax 
planning work flow for pharmaceutical enterprises, so as to help them to optimize 















strategy, operating characteristic and the current tax environment all in consideration, 
this paper made a detail analysis to the tax planning of this industry in the 
framework of invest, financing and operation activities, and expected that this detail 
analysis could provide as a guidance for pharmaceutical enterprises when they face 
similar problems. 
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